Board of Directors
Danielsen (born 1963) was elected to the Board in 2004 and appointed chairman in 2010. He holds an MBA in Finance and Swiss Business Law from the University of Fribourg in Switzerland, 1987. Since 1993, he has been acting as an independent health care analyst and consultant, advising both young growth companies as well as private and industrial investors on a variety of subjects including company evaluations, equity financing and operational communication strategies. Mr. Danielsen continues to support the activities of Bridge Relations Ltd, Analitika SA and Giulia Medical SA, companies he originally founded. In 2014 he assumed the role as CEO of Giulia Medical SA, a marketer of various medical technologies. Giulia Medical is predominantly focused on the Swiss market and is headquartered in Lugano, Switzerland.
Danielsen previously worked as an equity strategist and analyst for Credit Suisse in Zurich and Credit Suisse First Boston in New York. Danielsen is a board member of the following companies: Analitika SA, Giula Medical SA and Bridge Relations Ltd. As of December, 2016, he owns 4,500 shares in ContextVision through ORCA Ventures AG, a closely held investment company.
Hedlund (born 1952) is one of the founders of ContextVision. He finished his M.Sc. degree of Technology followed by further studies and research in image processing and GOP® theory at Linköping University. Hedlund was R&D and Site Manager in Linköping until 1999. Since then he has served as CTO, focusing on strategic product and business development. He has been a member of the Board since the company went public in 1997. He is also a board member of the wholly owned Yakivu AB and Slaka Invest.
As of December 31, 2016, Hedlund holds 831,666 shares (10,7%) in ContextVision.6
Jordanger (born 1953) was elected to the Board in 2002. Jordanger holds a BA degree from IMD Lausanne, Switzerland 1981. Throughout his career as an owner-manager, Jordanger has operated within various international industries and is presently the chairman or member of the following boards: Autogruppen AS, Autolink AS, Konsmo Fabrikker AS, Safe Information Group NV and Monsun AS.
As of December 31, 2016, Jordanger holds 2,248,750 (29,1%) shares through the company Monsun AS.
Bernadotte (born 1963) was elected to the Board in 2011. She holds a M.Sc. degree in Pharmacy from the University of Uppsala. Bernadotte has more than 25 years of experience from the Healthcare sector, through various marketing and sales positions, including international ones, within the American pharmaceutical company Merck/MSD and as Board member of LIF (Swedish Association of the Pharmaceutical industry) and AMCHAM (American Chamber of Commerce). Between 2006 and 2011 Bernadotte served as Managing Director of MSD Sweden. After that she took on the position as AVP Public Policy and Governmental Affairs in Brussels responsible for Europe and Canada. Since July 2015 Bernadotte is responsible for the Balkan region for MSD.
As of December 31, 2016, Bernadotte holds 6,500 shares in ContextVision.
Günther-Hanssen (born 1954) is one of the founders of ContextVision and he has previously served as CEO for the company, as well as board member. He was re-elected to the board in 2011. During later years Günther-Hanssen has acted as a venture capitalist and been involved in a number of start-up companies in the medical, industrial and financial sectors in the capacity of investor as well as board member. He holds a M.Sc. degree in Industrial Engineering from the Institute of Technology at Linköping University. Günther-Hanssen is a board member of wholly owned Skyhook AB.
As of December 31, 2016, Günther-Hanssen holds 851,667 shares (11%) in ContextVision.